• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外人红细胞Ca2+-ATP酶活性对甲状腺激素的反应随供体年龄增长而下降。

Donor age-dependent decline in response of human red cell Ca2+-ATPase activity to thyroid hormone in vitro.

作者信息

Davis P J, Davis F B, Blas S D, Schoenl M, Edwards L

出版信息

J Clin Endocrinol Metab. 1987 May;64(5):921-5. doi: 10.1210/jcem-64-5-921.

DOI:10.1210/jcem-64-5-921
PMID:3031121
Abstract

The effect of increasing donor age on the susceptibility of human red blood cell Ca2+-ATPase activity to stimulation in vitro by thyroid hormone was studied in 26 normal subjects, aged 15-81 yr. Basal enzyme activity (no added thyroid hormone) was unaffected by donor age. Group analysis, young (less than or equal to 50 yr) vs. elderly (greater than 60 yr old), revealed a 23% decrease in responsiveness of the enzyme to L-T4 (P less than 0.001). Regression analysis confirmed an age-dependent decline in thyroid hormone stimulability of Ca2+-ATPase [r = -0.42 (T4 effect) and -0.38 (T3 effect); P less than 0.01]. Red cell membrane Na,K-ATPase activity was not affected by donor age. Plasma T4 and T3 concentrations in these normal subjects also did not change with age. Possible contributions of the following mechanisms to this age-correlated change in enzyme activity were examined: altered responsiveness to calmodulin of membrane Ca2+-ATPase; membrane content of endogenous calmodulin, endogenous plasma T4 and T3 concentrations, and plasma glucose concentrations. Calmodulin responsiveness is required for iodothyronine action on the enzyme, but the calmodulin responsiveness of cells from elderly donors was not significantly different from that of cells from younger donors (P greater than 0.10). There was no relationship between membrane immunoassayable calmodulin and donor age or membrane calmodulin and Ca2+-ATPase activity. There were positive correlations between donor plasma T4 level and basal enzyme activity (P less than 0.05) and between donor plasma T3 concentration and hormone-responsive Ca2+-ATPase (P less than 0.01), but these did not contribute to the age effect. Plasma glucose previously was found to modulate red cell Ca2+-ATPase activity, but did not correlate with decreased hormone responsiveness of the enzyme in elderly donors. In conclusion, we found that the susceptibility of human red cell Ca2+-ATPase to in vitro thyroid hormone stimulation declined significantly with advancing donor age. Several possible calmodulin-dependent mechanisms for this age-dependent change were excluded, and thus, we postulate that the altered hormone sensitivity of the enzyme is membrane phospholipid mediated.

摘要

在26名年龄在15 - 81岁的正常受试者中,研究了供体年龄增加对人红细胞Ca2 + -ATP酶活性体外受甲状腺激素刺激敏感性的影响。基础酶活性(未添加甲状腺激素)不受供体年龄影响。分组分析,年轻组(小于或等于50岁)与老年组(大于60岁)比较,发现该酶对L - T4的反应性降低了23%(P < 0.001)。回归分析证实Ca2 + -ATP酶的甲状腺激素刺激能力存在年龄依赖性下降[r = -0.42(T4效应)和 -0.38(T3效应);P < 0.01]。红细胞膜Na,K - ATP酶活性不受供体年龄影响。这些正常受试者的血浆T4和T3浓度也不随年龄变化。研究了以下机制对这种与年龄相关的酶活性变化的可能作用:膜Ca2 + -ATP酶对钙调蛋白反应性的改变;内源性钙调蛋白的膜含量、内源性血浆T4和T3浓度以及血浆葡萄糖浓度。碘甲状腺原氨酸对该酶的作用需要钙调蛋白反应性,但老年供体细胞的钙调蛋白反应性与年轻供体细胞的钙调蛋白反应性无显著差异(P > 0.10)。膜免疫可检测的钙调蛋白与供体年龄或膜钙调蛋白与Ca2 + -ATP酶活性之间无相关性。供体血浆T4水平与基础酶活性之间呈正相关(P < 0.05),供体血浆T3浓度与激素反应性Ca2 + -ATP酶之间呈正相关(P < 0.01),但这些均未对年龄效应产生影响。先前发现血浆葡萄糖可调节红细胞Ca2 + -ATP酶活性,但与老年供体中该酶激素反应性降低无关。总之,我们发现随着供体年龄的增长,人红细胞Ca2 + -ATP酶对体外甲状腺激素刺激的敏感性显著下降。排除了几种可能的钙调蛋白依赖性机制对这种年龄依赖性变化的影响,因此,我们推测该酶激素敏感性的改变是由膜磷脂介导的。

相似文献

1
Donor age-dependent decline in response of human red cell Ca2+-ATPase activity to thyroid hormone in vitro.体外人红细胞Ca2+-ATP酶活性对甲状腺激素的反应随供体年龄增长而下降。
J Clin Endocrinol Metab. 1987 May;64(5):921-5. doi: 10.1210/jcem-64-5-921.
2
The effect of in vivo glucose administration on human erythrocyte Ca2+-ATPase activity and on enzyme responsiveness in vitro to thyroid hormone and calmodulin.体内给予葡萄糖对人红细胞Ca2+-ATP酶活性以及该酶体外对甲状腺激素和钙调蛋白反应性的影响。
Diabetes. 1985 Jul;34(7):639-46. doi: 10.2337/diab.34.7.639.
3
Effect of end-stage renal disease on responsiveness to calmodulin and thyroid hormone of calcium-ATPase in human red blood cells.终末期肾病对人红细胞中钙-ATP酶对钙调蛋白和甲状腺激素反应性的影响。
Kidney Int Suppl. 1983 Dec;16:S167-70.
4
Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.长链脂肪酸在体外对人红细胞膜中钙刺激、镁依赖的ATP酶活性的作用。
Biochem J. 1987 Dec 1;248(2):511-6. doi: 10.1042/bj2480511.
5
Thyroid hormone stimulation in vitro of red blood cell Ca2+-ATPase activity: interspecies variation.甲状腺激素体外刺激对红细胞钙-ATP酶活性的影响:种间差异。
Endocrinology. 1982 Jan;110(1):297-8. doi: 10.1210/endo-110-1-297.
6
Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity.甲状腺功能亢进和甲状腺功能减退对人红细胞Ca2+-ATP酶活性的影响。
J Clin Endocrinol Metab. 1986 Feb;62(2):253-7. doi: 10.1210/jcem-62-2-253.
7
Effects of caloric restriction and aging on erythrocyte membrane Ca(2+)-ATPase activity in specific pathogen-free Fischer 344 rats.
Metabolism. 1991 Aug;40(8):819-24. doi: 10.1016/0026-0495(91)90009-l.
8
Studies on the mechanism of thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.人红细胞Ca2+-ATP酶活性的甲状腺激素体外刺激机制研究。
Life Sci. 1982;30(7-8):675-82. doi: 10.1016/0024-3205(82)90283-1.
9
Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.甲状腺疾病和非甲状腺疾病中的红细胞钠/钾三磷酸腺苷酶
J Clin Endocrinol Metab. 1985 Jul;61(1):110-5. doi: 10.1210/jcem-61-1-110.
10
Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.苄普地尔和西替地尔在体外可逆转甲状腺激素对人红细胞Ca2 + -ATP酶活性的刺激作用。
Mol Endocrinol. 1987 Feb;1(2):168-71. doi: 10.1210/mend-1-2-168.

引用本文的文献

1
Age-Related Resistance to Thyroid Hormone Action.年龄相关的甲状腺激素作用抵抗。
Drugs Aging. 2019 Nov;36(11):1007-1014. doi: 10.1007/s40266-019-00711-7.
2
Mechanisms of age-related endocrine alterations. Part II.衰老相关内分泌改变的机制。第二部分。
Drugs Aging. 1993 Mar-Apr;3(2):131-46. doi: 10.2165/00002512-199303020-00004.